Lundbeck
HLUN-B.CO
#2542
Rank
A$10.07 B
Marketcap
A$10.15
Share price
2.16%
Change (1 day)
-6.48%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): A$1.12

According to Lundbeck's latest financial reports the company's current EPS (TTM) is A$1.09. In 2025 the company made an earnings per share (EPS) of A$0.73 an increase over its 2024 EPS that were of A$0.63.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.1254.37%
2025A$0.7314.5%
2024A$0.6329.29%
2023A$0.4923.09%
2022A$0.4037.26%
2021A$0.29-84.61%
2020A$1.89-24.61%
2019A$2.51-42.06%
2018A$4.3240.7%
2017A$3.07146.26%
2016A$1.25-120.48%
2015A-$6.093231.32%
2014A-$0.18-115.78%
2013A$1.16-23.36%
2012A$1.51-48.01%
2011A$2.91-9.68%
2010A$3.2213.72%
2009A$2.8324.32%
2008A$2.28-6.05%
2007A$2.4281.77%
2006A$1.33-16.76%
2005A$1.60-17.58%
2004A$1.94